image credit: Freepik

Innovation and collaboration – the MHRA’s pandemic approach

November 24, 2021


The pandemic has propelled issues for the pharmaceutical industry to the top of the political and public agenda, from clinical trial recruitment to the journey required for medicines or vaccines to reach patients.

The public knows now more than ever that the Medicines and Healthcare products Regulatory Agency (MHRA) ensures the safety and quality of vaccines and medicines, and that evidence from clinical trials is required for any treatment to be approved.

MSD recognises the excellence of the MHRA, and feel proud to have collaborated with them. Now, we must take the ways of working developed during the pandemic and embed these in the healthcare system.

Read More on Pharmaphorum